EFSA PRE-SUBMISSION GUIDANCE FOR APPLICANTS INTENDING TO SUBMIT APPLICATIONS FOR AUTHORISATION OF HEALTH CLAIMS MADE ON FOODS

Similar documents
Official Journal of the European Union L 109/11

Practical guidance for applicants on the submission of applications on food additives, food enzymes and food flavourings

COMMISSION REGULATION (EU)

1 OJ L 354, , p OJ L 80, , p. 19.

European Commission request to the European Food Safety Authority for scientific advice on:

SCIENTIFIC AND TECHNICAL GUIDANCE FOR THE PREPARATION AND PRESENTATION OF THE APPLICATION FOR AUTHORISATION OF A HEALTH CLAIM

1 OJ L 354, , p OJ L 80, , p. 19.

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2. European Food Safety Authority (EFSA), Parma, Italy

Laura Beatriz Herrero Montarelo, Maria Dolores Gómez Vázquez and Victorio José Teruel Muñoz

SCIENTIFIC AND TECHNICAL GUIDANCE FOR THE PREPARATION AND PRESENTATION OF THE APPLICATION FOR AUTHORISATION OF A HEALTH CLAIM

EFSA Publication; Tetens, Inge. Link to article, DOI: /j.efsa Publication date: 2011

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2. European Food Safety Authority (EFSA), Parma, Italy

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DENLEG 51 CODEC 893

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2. European Food Safety Authority (EFSA), Parma, Italy

Parma, 21/09/2015 SCIENTIFIC EVALUATION OF REGULATED PRODUCTS DEPARTMENT

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 21 October 2015

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2. European Food Safety Authority (EFSA), Parma, Italy

(Legislative acts) REGULATIONS

EFSA Statement regarding the EU assessment of glyphosate and the socalled

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2,3. European Food Safety Authority (EFSA), Parma, Italy

APPROVED: 14 April 2015 PUBLISHED: 17 April 2015

Working Document prepared by the Commission services - does not prejudice the Commission's final decision 3/2/2014 COMMISSION STAFF WORKING DOCUMENT

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

Guideline on influenza vaccines submission and procedural requirements

SCIENTIFIC OPINION. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies. (Question No EFSA-Q )

SCIENTIFIC OPINION. Lipil and brain development

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2,3. European Food Safety Authority (EFSA), Parma, Italy

C 178/2 Official Journal of the European Union

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

Official Journal of the European Union REGULATIONS

Niacin and contribution to normal energy-yielding metabolism: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

ADOPTED: 28 October 2015 PUBLISHED: 13 November 2015

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3 SUMMARY. European Food Safety Authority (EFSA), Parma, Italy

COMMISSION REGULATION (EU) / of XXX

REGULATION (EC) No.141/2000

(Text with EEA relevance)

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

COMMISSION REGULATION (EU) / of XXX

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2,3. European Food Safety Authority (EFSA), Parma, Italy

Delegations will find attached document D048379/05.

Procedural advice on the submission of variations for annual update of human influenza inactivated vaccines applications in the centralised procedure

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Pesticide risk assessment: changes and perspectives for mammalian toxicology in the new EC regulation 1107/2009

IMPORTANT DISCLAIMER. Note

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

Statement on the conditions of use for health claims related to meal replacements for weight control

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

COMMISSION DELEGATED REGULATION (EU).../... of XXX

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

TECHNICAL REPORT OF EFSA

COMMISSION REGULATION (EU) / of XXX. establishing mitigation measures and benchmark levels for the reduction of the presence of acrylamide in food

COMMISSION REGULATION (EU) / of XXX. establishing mitigation measures and benchmark levels for the reduction of the presence of acrylamide in food

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. Melgaço mineral water and reduction of glycaemia. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Administrative guidance to applicants on the preparation and presentation of applications for authorisation of additives for use in animal nutrition

Official Journal of the European Union

COMMISSION REGULATION (EU) / of XXX. authorising certain health claims made on foods and referring to children's development and health

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 13 JUNE 2014

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

The Nutrition (Amendment) (EU Exit) Regulations 2018

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014.

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015

TECHNICAL REPORT OF EFSA. List of guidance, guidelines and working documents developed or in use by EFSA 1

SCIENTIFIC OPINION. Kinder Chocolate and growth

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

TECHNICAL REPORT. European Food Safety Authority 2, 3. European Food Safety Authority (EFSA), Parma, Italy

DIRECTIVES. (Text with EEA relevance)

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 10 DECEMBER 2012 (Section General Food Law)

COMMISSION IMPLEMENTING DECISION. of XXX

The Chartered Society of Physiotherapy Complaints Procedure

SCIENTIFIC OPINION. (Question No EFSA-Q ) Adopted on 15 May 2009

Which foods may carry nutrition and health claims? Update from EFSA

COUNCIL OF THE EUROPEAN UNION. Brussels, 15 November 2005 (OR. en) 9858/05 Interinstitutional File: 2003/0165 (COD) DENLEG 25 SAN 105 CODEC 481 OC 382

Københavns Universitet

New Novel Food Regulation

Scientific Opinion on the substantiation of a health claim related to a combination of thiamin, riboflavin, niacin, pantothenic acid, pyridoxine,

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2, 3. European Food Safety Authority (EFSA), Parma, Italy

Delegations will find attached document D042445/02.

COMMISSION DELEGATED REGULATION (EU) /... of XXX

Procedural advice on publication of information on withdrawals of applications related to the marketing authorisation of human medicinal products

DECISIONS. (Only the Dutch and French texts are authentic) (Text with EEA relevance)

Transcription:

EFSA PRE-SUBMISSION GUIDANCE FOR APPLICANTS INTENDING TO SUBMIT APPLICATIONS FOR AUTHORISATION OF HEALTH CLAIMS MADE ON FOODS Last updated (Rev.): 21 December 2007 Publication Date: 14 March 2007 NOTES to users: The information provided in this guidance document should be cross-read in conjunction with the Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health * (hereafter the Regulation ). This guidance document addresses a number of administrative and procedural questions which applicants intending to submit applications for health claims authorisation may have. It provides an overview of issues related to the afore-mentioned procedure and aims to assist applicants in the submission of applications. Questions and Answers will be updated progressively, and will be marked by New or Rev." upon publication. EFSA advises applicants to check the most recent version before submitting an application. For questions related to the format and content of the application for authorisation of a health claim, please refer to the EFSA adopted Opinion on scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim : http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guidance_health_claim s.html * Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health. Official Journal of the European Union OJ L 404, 30.12.2006. Corrigendum OJ L 12, 18.1.2007, p. 3 18. http://eur-lex.europa.eu/lexuriserv/site/en/oj/2007/l_012/l_01220070118en00030018.pdf European Food Safety Authority, 2007 Page 1/18

LIST OF QUESTIONS 1. Is my application for authorisation of a health claim eligible for scientific evaluation by EFSA? Rev. 2. Is my application for authorisation of a health claim eligible for scientific evaluation by EFSA under the scope of Article 14 procedure? 3. Is my application for authorisation of a health claim eligible for scientific evaluation by EFSA under the scope of Article 18 procedure? Rev. 4. How should I organise my application for health claim authorisation and under which format? 5. How should my Summary of the Application look like? Rev. 6. Can I submit multiple health claims in the same application? 7. What is the procedure for the submission of applications for authorisation of health claims? Rev. 8. How shall I submit an application based on proprietary data? 9. How shall I submit an application containing confidential data? 10. If my application cites references, and encloses copies/reprints of published or unpublished data, how shall I address their Intellectual Property Rights? 11. In which language shall I submit my application? 12. How and to whom shall I submit my application?. How many paper copies? 13. Can I submit electronic copies of my dossier? Rev. 14. Where can I find the List of National Competent Authorities within the framework of the Regulation? Rev. 15. When shall I submit my application? Rev 16. How shall my application be validated? Rev 17. How shall my application be evaluated (timetable)? 18. How and when is an EFSA application Number attributed? 19. Is there Guidance available to help me to prepare my application for authorisation of a health claim? 20. How can I communicate with EFSA or the Panel during the evaluation process of my application and who is the EFSA contact person for my application? 21. If I have questions related to the interpretation of the scope of the regulation or on the authorisation procedure, who shall I contact? 22. What is the role of EFSA & the NDA Panel under the context of the Regulation? New European Food Safety Authority, 2007 Page 2/18

RESPONSES 1. Is my application for authorisation of a health claim eligible for scientific evaluation by EFSA? Rev. The Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health lays down the following provisions: For health claims which fall under Article 14 of the Regulation, i.e. Health claim referring to reduction of disease risk (meaning any health claim that states, suggests or implies that the consumption of a food category, a food or one of its constituents significantly reduces a risk factor in the development of human disease). Health claim referring to children s development and health. an application is needed. Applications for authorisation are subject to scientific evaluation (i.e. scientific Opinion) by EFSA according to the procedure laid down in Articles 15, 16, 17 and 19 of the Regulation, prior to their inclusion in a Community list of permitted claims. Health claims (other than those referring to the reduction of disease risk and to children s development and health) which fall under Article 13(1) of the Regulation, i.e. health claims describing or referring to: the role of a nutrient or other substance in growth, development and the functions of the body, or psychological and behavioural functions; or slimming or weight-control or a reduction in the sense of hunger or an increase in the sense of satiety or to the reduction of the available energy from the diet, have to be included in the Community list of permitted claims provided for under Article 13(3) of the Regulation. For inclusion in the afore-mentioned Community list of permitted claims, PLEASE CONTACT: the National Competent Authority of a Member State in the EU where the health claim applies; or alternatively the European Commission, Unit E4 of Directorate General Health and Consumer Protection, Rue de la Loi 200, B-1049 Bruxelles, Belgium (http://ec.europa.eu/comm/food/index_en.htm; http://ec.europa.eu/food/food/labellingnutrition/claims/index _en.htm). For health claims (other than those referring to the reduction of disease risk and to children s development and health) which fall under Article 13(5) of the Regulation, i.e. health claims which have not been included in the Community list of permitted claims, which are: - based on newly developed scientific evidence and/or which - include a request for the protection of proprietary data European Food Safety Authority, 2007 Page 3/18

an application is needed. Applications for authorisation are subject to scientific evaluation (i.e. scientific Opinion) by EFSA according to the procedure laid down in Article 18 of the Regulation, prior to their addition to the list of permitted health claims referred to in Article 13(3) of the Regulation. As regards the classification of claims under one of the categories identified above, applicants are kindly invited to refer to the European Commission Guidance on the implementation of Regulation 1924/2006 on nutrition & health claims made on foods Conclusions of the Standing Committee on the Food Chain and Animal Health dated 14 December 07 (the link to the webpage will be given once the afore-mentioned guidance is published by the Commission). 2. Is my application for authorisation of a health claim eligible for scientific evaluation by EFSA under the scope of Article 14 procedure? Article 14 procedure: Art 14 of the Regulation applies only to health claims referring to: reduction of disease risk (meaning any health claim that states, suggests or implies that the consumption of a food category, a food or one of its constituents significantly reduces a risk factor in the development of human disease). children s development and health. For such health claims an application is needed. Applications for authorisation are therefore subject to scientific evaluation (i.e. scientific Opinion) by EFSA according to the procedure laid down in Articles 15, 16, 17 and 19 of the Regulation, prior to their inclusion in a Community list of permitted claims. 3. Is my application for authorisation of a health claim eligible for scientific evaluation by EFSA under the scope of Article 18 procedure? Rev. Article 18 procedure: Article 18 of the Regulation applies only to health claims (other than those referring to the reduction of disease risk and to children s development and health) referred to in Article 13(5), i.e. which have not been included in the Community list of permitted health claims under the provision of Article 13(3), which are: - based on newly developed scientific evidence and/or which - include a request for the protection of proprietary data. For such health claims an application is needed. Applications for authorisation are subject to scientific evaluation (i.e. scientific Opinion) by EFSA according to the procedure laid down in Article 18 of the Regulation, prior to their addition to the list of permitted health claims referred to in Article 13(3) of the Regulation. European Food Safety Authority, 2007 Page 4/18

4. How should I organise my application for health claim authorisation and under which format? Format According to Article 15(4) of the Regulation*, The Commission, having first consulted EFSA, shall establish in accordance with the procedure referred to in Article 25(2) (comitology procedure) implementing rules for the application of this Article, including rules concerning the preparation and presentation of the application. Upon the request from the European Commission, EFSA Scientific Panel on Dietetic products, Nutrition and Allergies (NDA Panel) has adopted an Opinion on scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim (hereafter referred to as the Guidance ) after having released it for public consultation and taking into consideration all comments received. The Guidance presents a common format for the organisation of the information to assist the applicant in the preparation of a well-structured application. Adherence to this format will also facilitate easy access to information and scientific data in applications to help the NDA Panel with its evaluation in an effective and consistent way. To streamline and optimise the authorisation process of the health claim applied for, EFSA strongly advises the applicant to adhere to the Guidance for preparing their application for authorisation of a health claim before submitting it for scientific evaluation by EFSA (http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guidance_heal th_claims.html). To facilitate the preparation of the application for health claim authorisation, a readyto-use word-format of the application including Templates is also provided: http://www.efsa.europa.eu/en/science/nda/pre_submission_guidance/nda_technical_g uidance.html. 5. How should my Summary of the Application look like? Rev. Summary of the Application: According to Articles 15(2b) and 15(3g) of the Regulation, the application shall be accompanied by a Summary of the Application, and EFSA shall make the Summary of the Application available to the public. The Summary of the Application should be presented in a standardised form. Therefore it is mandatory to use the form provided in the Appendix B of the Guidance (http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guidance_heal th_claims.html). To facilitate the preparation of the Summary of the Application, a ready-to-use word-format of the application including Templates is also provided: European Food Safety Authority, 2007 Page 5/18

http://www.efsa.europa.eu/en/science/nda/pre_submission_guidance/nda_technical_g uidance.html. The Summary of the Application shall be preferably presented in English in an easily comprehensible and legible form. It should be brief and concise, and reflect the information in the application. The Summary of the Application shall not contain parts which are considered to be confidential as it will be published on the EFSA website following receipt of the application from a National Competent Authority of a Member State. Acknowledging the above, applicants are encouraged for transparency purpose to make publicly available a maximum of information submitted in the Summary of Application. For publication purposes, an electronic file containing exclusively the Summary of the Application should be provided (http://www.efsa.europa.eu/efsa/efsa_locale- 1178620753812_1178623592471.htm). 6. Can I submit multiple health claims in the same application? An application should be prepared for each individual health claim; this means that only one relationship between a food/constituent (Notes: food/constituent refers to the food category, a food, or constituents (including a nutrient or other substance, or a combination of nutrients/other substances) for which the health claim is made) and a single claimed effect can be the object of each application. If multiple claimed effects are proposed for a food/constituent, a separate application should be submitted for each claimed effect. For the presentation and format of the application for health claim authorisation, please refer to the EFSA adopted Opinion on scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim (http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guidance_heal th_claims.html). The Guidance presents a common format for the organisation of the information to assist the applicant in the preparation of a well-structured application. Adherence to this format will also facilitate easy access to information and scientific data in applications to help the NDA Panel with its evaluation in an effective and consistent way. To streamline and optimise the authorisation process of the health claim applied for, EFSA strongly advises the applicant to adhere to the Guidance when preparing their application for authorisation of a health claim to be evaluated by EFSA. European Food Safety Authority, 2007 Page 6/18

7. What is the procedure for the submission of applications for authorisation of health claims? Rev. Procedure: Applications for authorisation of health claims pursuant to Articles 14 and 13(5) of the Regulation (EC) No 1924/2006 shall be submitted to the National Competent Authority of a Member State in the European Union in accordance with Articles 15 and 18, respectively. The National Competent Authority of the Member State shall then make the application and any supplementary information supplied by the applicant available to EFSA at the following mailing address: European Food Safety Authority Scientific Coordinator NDA Panel Quoting the reference Ref: efsa-nda-claims Address: Largo N. Palli 5/A, I-43100 Parma, Italy Email: efsa-nda-claims@efsa.europa.eu Fax: +39 0521 036 175 Subsequently, EFSA will follow the procedure as laid down in the CHART below. Evaluation & Authorisation Procedure Applicant Submission of Application National Competent Authority of a Member State in the EU Receipt of Application EFSA Receipt of Application Inform & make Application available to Commission/other Member States EFSA Validation process Publication of Summary of Application on EFSA Web Day 0: EFSA NDA Panel Scientific evaluation process Day=5(7 months *): EFSA NDA Panel Adopted Opinion EFSA Publication of Adopted Opinion on EFSA web Commission Community Authorisation * Evaluation procedure including clock stop mechanism for request of supplementary information if needed European Food Safety Authority, 2007 Page 7/18

Please be advised that it is not for the EFSA to authorise the use of a health claim. The authorisation of claims is under the remit of the European Commission. After scientific evaluation (i.e. scientific Opinion) by EFSA of the application received from the National Competent Authority of a Member State, the Commission will take the decision concerning the authorisation of the health claim applied for. 8. How shall I submit an application based on proprietary data? Proprietary data: Article 21 of the Regulation gives provision for the handling of proprietary data in the application required under Article 15(3). The application for authorisation of a health claim shall clearly state which parts or sections of the application are considered to be proprietary data, together with a verifiable justification/declaration by the applicant. For presentation and submission of applications based on proprietary data, please refer to the EFSA adopted Opinion on scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim (http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guidance_heal th_claims.html). The Guidance presents a common format for the organisation of the information to assist the applicant in the preparation of a well-structured application. Adherence to this format will also facilitate easy access to information and scientific data in applications to help the NDA Panel with its evaluation in an effective and consistent way. To streamline and optimise the authorisation process of the health claim applied for, EFSA strongly advises the applicant to adhere to the Guidance when preparing their application for authorisation of a health claim to be evaluated by EFSA. 9. How shall I submit an application containing confidential data? Confidential data: The whole application in itself cannot be confidential. Sections considered as confidential by the applicant should be kept to a minimum. The application for authorisation of a health claim shall clearly state which parts or sections of the application are considered to be confidential, together with a verifiable justification/declaration by the applicant for each part or section considered to be confidential. When dealing with confidential data, EFSA will apply Articles 8 and 9 of the decision of its management board concerning implementing measures of transparency and confidentiality requirements (link to website: European Food Safety Authority, 2007 Page 8/18

http://www.efsa.europa.eu/etc/medialib/efsa/mboard/statutory_texts/internal_rules/40 9.Par.0011.File.dat/mb_transparency_confidentiality_requirements1.pdf). For presentation and submission of applications including confidential data, please refer to the EFSA adopted Opinion on scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim (http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guidance_heal th_claims.html). The Guidance presents a common format for the organisation of the information to assist the applicant in the preparation of a well-structured application. Adherence to this format will also facilitate easy access to information and scientific data in applications to help the NDA Panel with its evaluation in an effective and consistent way. To streamline and optimise the authorisation process of the health claim applied for, EFSA strongly advises the applicant to adhere to the Guidance when preparing their application for authorisation of a health claim to be evaluated by EFSA. 10. If my application cites references, and encloses copies/reprints of published or unpublished data, how shall I address their Intellectual Property Rights? Applicants are responsible of all references cited, published or unpublished, and for obtaining permission to reproduce, distribute or communicate such material from the concerned holder of an Intellectual Property Rights. 11. In which language shall I submit my application? Languages to be used: In order to facilitate the processing of the application and make the assessment more efficient, applications should preferably be submitted in English. Should the applicant not provide the English translation, the EFSA will translate those parts of the application in English. However, it should be noted that the responsibility for validating the English translation of the application provided by the EFSA rests with the applicant. 12. How and to whom shall I submit my application? Dossier requirements: The paper copy remains the formal submission. In case of discrepancies between the paper copy and the electronic one, EFSA will consider the paper one as the correct version and will ask the applicant an updated electronic version of the application. It is strongly recommended that both paper and electronic submissions fully be in compliance with the EFSA adopted Opinion on scientific and technical guidance for European Food Safety Authority, 2007 Page 9/18

the preparation and presentation of the application for authorisation of a health claim (http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guidance_heal th_claims.html). Applicants must submit applications for health claim authorisation and written responses to questions from EFSA as follows: Number of copies: For EFSA = one paper copy + one electronic copy. Additional copies may be required either by EFSA or the National Competent Authority of the Member State. Applicants are advised to contact the National Competent Authority of the Member State for specific requirements prior to submission of applications for health claim authorisation to Member States. Please refer to the List of National Competent Authorities within the framework of the Regulation as prepared by the European Commission. In the event that EFSA asks the applicant for additional data or information in the process of validation of the application, the applicant should send that information to EFSA as requested. After validation of the application by EFSA, the applicant will be requested to send to EFSA within a notified period: 3 paper copies + 5 electronic copies of the complete application (including any additional data or information supplied during the validation phase), unless otherwise specified. In case additional copies are requested, EFSA will inform applicants of the exact number of copies required. Written responses to questions from EFSA: 3 paper copies + 5 electronic copies, unless otherwise specified. If in individual situations there is any divergence from the standard requirement, EFSA will inform the applicant accordingly. Each box containing the application should weigh less than 15 kg. All boxes should be numbered and labelled, indicating which part of the application is contained inside. Boxes containing the cover letter and diskettes/cd-roms should be clearly identified. For information about submission of electronic copies of the application, please see electronic submissions. a. How many paper copies? Number of copies: For EFSA = one paper copy + one electronic copy. European Food Safety Authority, 2007 Page 10/18

For the National Competent Authorities requirement, applicants are advised to contact the National Competent Authority of the Member State for specific requirements. Please refer to the List of National Competent Authorities within the framework of the Regulation as prepared by the European Commission. In the event that EFSA asks the applicant for additional data or information in the process of validation of the application, the applicant should send that information to EFSA as requested. After validation of the application by EFSA, the applicant is requested to send to EFSA within a notified period: 3 paper copies + 5 electronic copies of the completed application (including any additional data or information supplied during the validation phase), unless otherwise specified. In case additional copies are requested, EFSA will inform applicants of the exact number of copies required. Written responses to questions from EFSA: 3 paper copies + 5 electronic copies, unless otherwise specified. If in individual situations there is any divergence from the standard requirement, EFSA will inform the applicant accordingly. Each box containing the application should weigh less than 15 kg. All boxes should be numbered and labelled, indicating which part of the application is contained inside. Boxes containing the cover letter and diskettes/cd-roms should be clearly identified. 13. Can I submit electronic copies of my dossier? Rev. Electronic submissions Besides the submission of hard copies (i.e. paper copies) of the dossier, the submission of complete copies using an electronic storage media is required. Common electronic formats should be used, such as MS Office type documents or Adobe Acrobat Reader. The files should be searchable using the search facilities of standard software packages. Applicants must sign a letter in which they confirm that the electronic data supplied are identical to those in any written submission. The paper copy remains the formal submission. In case of discrepancies between the paper copy and the electronic one, EFSA will consider the paper one as the correct version and will ask the applicant an updated electronic version of the application. It is strongly recommended that both paper and electronic submissions fully be in compliance with the EFSA adopted Opinion on scientific and technical guidance for European Food Safety Authority, 2007 Page 11/18

the preparation and presentation of the application for authorisation of a health claim (http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guidance_heal th_claims.html). For publication purposes, an electronic file containing exclusively the Summary of the Application should be provided (http://www.efsa.europa.eu/efsa/efsa_locale- 1178620753812_1178623592471.htm). For the National Competent Authorities requirements, applicants are advised to contact the National Competent Authority of the Member State. 14. Where can I find the list of National Competent Authorities within the framework of the Regulation? Rev. List of National Competent Authorities within the framework of the Regulation: The List is prepared by the European Commission. The List indicates the addresses for submission points including the contact persons in charge in the National Competent Authorities in the European Union Member-States. Please be advised that applications for authorisation of health claims pursuant to Articles 14 and 13(5) of the Regulation (EC) No 1924/2006 shall be submitted to the National Competent Authority of a Member State in the European Union in accordance with Articles 15 and 18, respectively. Applicants are advised to contact the National Competent Authority of the Member State for specific requirements prior to submission of applications for health claim authorisation to Member States. 15. When shall I submit my application? Rev. Application for authorisation of a health claim as referred to in Article 14 of the Regulation can be submitted to the National Competent Authority of a Member State in the EU for scientific evaluation by EFSA as from 1 July 2007. To streamline and optimise the authorisation process of the health claim applied for, EFSA strongly advises the applicant to adhere to the EFSA adopted Opinion on scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim for preparing their application for authorisation of a health claim before submitting it for scientific evaluation by EFSA (http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guida nce_health_claims.html). For addition of health claims referred to in Article 13(5), i.e. which have not been included in the Community list of permitted claims under the European Food Safety Authority, 2007 Page 12/18

provision of Article 13(3), which are based on newly developed scientific evidence and/or which include a request for the protection of proprietary data, application for authorisation in accordance with the procedure laid down in Article 18 of the Regulation can be submitted to the National Competent Authority of a Member State in the European Union for scientific evaluation by EFSA as from 1 February 2008. To streamline and optimise the authorisation process of the health claim applied for, EFSA strongly advises the applicant to adhere to the EFSA adopted Opinion on scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim when preparing their application for authorisation of a health claim to be evaluated by EFSA (http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guida nce_health_claims.html). Please be advised that it is not for the EFSA to authorise the use of a health claim. The authorisation of claims is under the remit of the European Commission. After scientific evaluation (i.e. scientific Opinion) by EFSA of the application received from the National Competent Authority of a Member State, the Commission will take the decision concerning the authorisation of the health claim applied for. 16. How shall my application be validated? Rev. Validation by EFSA Upon receipt of the application from the National Competent Authority of a Member State, EFSA will proceed with its administrative checking. EFSA will start the scientific evaluation procedure of the submission when it will have completed its validation; the timetable for each application will be published on the EFSA website (http://www.efsa.europa.eu/en/science/nda.html). During validation EFSA may consult the NDA Panel on the need for action relating to matters such as completeness of data. If relevant, the Commission Services will be consulted on points of interpretation of EU legislation particularly in relation to the scope. In the event that EFSA requires additional data, information or clarification in order to consider an application valid, the applicant will be asked to supply these data, information or clarification within a notified time limit. When supplying EFSA with this information, the applicant should send the requested number of paper copies of this information to EFSA together with the electronic version, as indicated by EFSA. In this case, the validation can only be completed after receipt and verification by EFSA of the information submitted. To streamline and optimise the validation process of the health claim applied for, EFSA strongly advises the applicant: European Food Safety Authority, 2007 Page 13/18

To check that the application applied for is under the right scope, by referring to the European Commission Guidance on the implementation of Regulation 1924/2006 on nutrition & health Conclusions of the Standing Committee on the Food Chain and Animal Health dated 14 December 07 (the link to the webpage will be given once the afore-mentioned guidance is published by the Commission). To adhere to the EFSA adopted Opinion on scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim when preparing their application for authorisation of a health claim to be evaluated by EFSA (http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guida nce_health_claims.html). 17. How shall my application be evaluated (timetable)? Timetable for the evaluation of the application for authorisation: Once the application is validated, EFSA starts the scientific evaluation procedure. A timetable for each application is prepared by EFSA; the starting date and evaluation timetable are published on the EFSA website (http://www.efsa.europa.eu/en/science/nda.html). EFSA shall ensure that the Opinion of the Scientific Panel on Dietetic products, Nutrition and Allergies (NDA Panel) is given within 5 months (plus clock-stops for the applicant to provide answers to questions from EFSA, if needed) in accordance with the following timetable as referred to in the CHART below. European Food Safety Authority, 2007 Page 14/18

Evaluation & Authorisation Procedure Applicant Submission of Application National Competent Authority of a Member State in the EU Receipt of Application EFSA Receipt of Application Inform & make Application available to Commission/other Member States EFSA Validation process Publication of Summary of Application on EFSA Web Day 0: EFSA NDA Panel Scientific evaluation process Day=5(7 months *): EFSA NDA Panel Adopted Opinion EFSA Publication of Adopted Opinion on EFSA web Commission Community Authorisation * Evaluation procedure including clock stop mechanism for request of supplementary information if needed 18. How and when is an EFSA application Number attributed? Management of applications: Upon receipt of an application, details of the application are entered into an EFSA database and tracking system. An application Number will be attributed to the application for authorisation of the health claim received. This number, which is given after the submission of the application and published on the EFSA website at the start of the scientific evaluation procedure, is retained throughout the life cycle of the application. These numbers are used as a reference by EFSA and should be used by the Applicant in all correspondence with EFSA throughout the life cycle of the application. European Food Safety Authority, 2007 Page 15/18

19. Is there Guidance available to help me to prepare my application for authorisation of a health claim? Guidance available: According to Article 15(4) of the Regulation*, The Commission, having first consulted EFSA, shall establish in accordance with the procedure referred to in Article 25(2) (comitology procedure) implementing rules for the application of this Article, including rules concerning the preparation and presentation of the application. Upon the request from the European Commission, EFSA Scientific Panel on Dietetic products, Nutrition and Allergies (NDA Panel) has adopted an Opinion on scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim (hereafter referred to as the Guidance ) after having released it for public consultation and taking into consideration all comments received. The Guidance presents a common format for the organisation of the information to assist the applicant in the preparation of a well-structured application. Adherence to this format will also facilitate easy access to information and scientific data in applications to help the NDA Panel with its evaluation in an effective and consistent way. To streamline and optimise the authorisation process of the health claim applied for, EFSA strongly advises the applicant to adhere to the Guidance when preparing their application for authorisation of a health claim to be evaluated by EFSA (http://www.efsa.europa.eu/en/science/nda/nda_opinions/claims/ej530_guidance_heal th_claims.html). Working-format of the application: To facilitate the preparation of the application for health claim authorisation, a readyto-use word-format of the application including Templates is also provided: http://www.efsa.europa.eu/en/science/nda/pre_submission_guidance/nda_technical_g uidance.html. 20. How can I communicate with EFSA or the Panel during the evaluation process of my application and who is the EFSA contact person for my application? Communication with EFSA or its scientific Panel on Dietetic products, Nutrition and Allergies: In accordance with the Rules of Procedure of the EFSA Scientific Committee and Panels 1, please be advised that any question from an applicant or a third party to any of the members of the EFSA Panels should be addressed through the EFSA scientific Secretariat. The contact details of the NDA Secretariat are available on the EFSA web site 2. European Food Safety Authority, 2007 Page 16/18

For questions related to the procedural and administrative aspects of applications for authorisation of health claims, the applicants could contact: - Dr. Pilar Rodríguez Iglesias / Dr. Leng Heng Email: efsa-nda-claims@efsa.europa.eu Fax: +39 0521 036 175 References: http://www.efsa.europa.eu/mboard/statutory_texts/internal_rules/409/decision_panels _mb_04_en11.pdf 2 http://www.efsa.europa.eu/en/about_efsa/contact_us.html 21. If I have questions related to the interpretation of the regulation or on the authorisation procedure, who shall I contact? Contact point: Please be advised that for questions related to such as interpretation of the Regulation (e.g. the scope) or concerning the authorisation procedure of a health claim, they are under the remit of the European Commission. Therefore, you may wish also to contact: European Commission, Unit E4 of Directorate General Health and Consumer Protection, Rue de la Loi 200, B-1049 Bruxelles, Belgium (http://ec.europa.eu/comm/food/index_en.htm; http://ec.europa.eu/food/food/labellingnutrition/claims/index_en.htm). 22. What is the role of EFSA & the NDA Panel under the context of the Regulation? New Role of EFSA: In the context of the authorisation procedures foreseen in the Health and Nutrition Claims Regulation, the role of the EFSA is to evaluate the scientific substantiation of individual applications (adopting a scientific Opinion). The EFSA has allocated this task to its Scientific Panel on Dietetic Products, Nutrition and Allergies ( the NDA Panel ). Please note that in the context of the authorisation procedures foreseen in the Nutrition and Health Claims Regulation, the EFSA is not supposed to undertake a safety evaluation of products or substances in respect of which a claim is to be made. In that regard, it is for the applicants to comply with the relevant legislation applicable to those products or substances. Once available, EFSA scientific Opinion is published on its website. European Food Safety Authority, 2007 Page 17/18

Please be advised that it is not for the EFSA to authorise the use of a health claim. The authorisation of claims is under the remit of the European Commission. After scientific evaluation (i.e. scientific Opinion) by EFSA of the application received from the National Competent Authority of a Member State, the Commission will take the decision concerning the authorisation of the health claim applied for. European Food Safety Authority, 2007 Page 18/18